These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9806470)

  • 1. Molecular diagnostics for cardiovascular disease.
    Pang CP
    Clin Chem Lab Med; 1998 Aug; 36(8):605-14. PubMed ID: 9806470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].
    Mariotti S; Capparuccia C; Ripa C; Olivieri F; Lisa R; Procopio A; Antonicelli R
    G Ital Cardiol (Rome); 2010 Oct; 11(10):730-45. PubMed ID: 21246774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of neuromuscular disorders.
    Laing NG
    Crit Rev Clin Lab Sci; 2012; 49(2):33-48. PubMed ID: 22468856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental modulation of postprandial lipemia: from a better knowledge of the mechanisms to a more effective treatment strategy.
    Annuzzi G
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):169-72. PubMed ID: 18342241
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease: genes and public health.
    Harrap SB
    Ann Acad Med Singap; 2000 May; 29(3):279-83. PubMed ID: 10976379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics and dyslipidemias].
    Brousseau T; Fruchart JCh
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1116-20. PubMed ID: 14694789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular diseases: present and future based on molecular biology].
    Oseguera Moguel J
    Rev Invest Clin; 2003; 55(2):155-60. PubMed ID: 12827919
    [No Abstract]   [Full Text] [Related]  

  • 12. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease.
    Humphries SE
    Clin Chim Acta; 1993 Jul; 216(1-2):S5-18. PubMed ID: 8222258
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
    Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
    Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of genetic mutation in familial Hirschsprung's disease in South Africa: towards genetic counseling.
    Moore SW; Zaahl MG
    J Pediatr Surg; 2008 Feb; 43(2):325-9. PubMed ID: 18280283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.
    Richard P; Gaudon K; Haddad H; Ammar AB; Genin E; Bauché S; Paturneau-Jouas M; Müller JS; Lochmüller H; Grid D; Hamri A; Nouioua S; Tazir M; Mayer M; Desnuelle C; Barois A; Chabrol B; Pouget J; Koenig J; Gouider-Khouja N; Hentati F; Eymard B; Hantaï D
    Neurology; 2008 Dec; 71(24):1967-72. PubMed ID: 19064877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene.
    Chaki M; Mukhopadhyay A; Chatterjee S; Das M; Samanta S; Ray K
    Mol Vis; 2005 Jul; 11():531-4. PubMed ID: 16056219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mutations in the RB1 gene by single strand conformation polymorphism (SSCP) analysis, amplification mismatch detection (AMD) analysis and polymerase chain reaction sequencing.
    Dundar M; Lanyon GW; Connor MJ
    Proc Natl Sci Counc Repub China B; 2001 Jul; 25(3):166-73. PubMed ID: 11480772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From candidate gene to genome-wide association studies in cardiovascular disease.
    Gianfagna F; Cugino D; Santimone I; Iacoviello L
    Thromb Res; 2012 Mar; 129(3):320-4. PubMed ID: 22154244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
    Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.